Teva Pharmaceutical Q2 2023 Earnings Results

Loading viewer...

earnings

Format: PDF earnings

Teva Pharmaceutical Industries presents second quarter 2023 financial results and operational performance, covering generic pharmaceuticals, innovative medicines including AUSTEDO and COPAXONE, and biosimilar portfolio development. The presentation addresses competitive positioning, pipeline strategies, and risk factors affecting the company's outlook in a dynamic pharmaceutical market.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Teva Pharmaceutical Industries Ltd.

View all →

Teva Pharmaceutical 2024 J.P. Morgan Healthcare Conference

conference

18 Pages

Teva Pharmaceutical Q1 2022 Results

earnings

Similar earningss from other companies

Browse all →

Intact Financial Corporation Q1 2022 Earnings Review

earnings

16 Pages

Intact Financial Corporation

Nikola Corporation Q4 FY2022 Earnings Presentation

earnings